BioAsia 2023 – Central News Hub

BioAsia 2023 to host innovation zone for startups

BioAsia 2023 will be held in Hyderabad from February 24 to 26…reports Asian Lite News

BioAsia 2023, Asia’s largest life-sciences and healthcare conference, will host a startup showcase, a platform for promising startups in the healthcare and life sciences ecosystem.

The Innovation Zone’ at the life sciences event, organised by the Telangana government, will feature a startup stage pavilion and an incubator pavilion.

BioAsia 2023 will be held in Hyderabad from February 24 to 26.

With its commitment to driving innovation, over 75 short-listed startups are being given participation fee waivers in addition to a free display booth. The event aims to provide promising startups focused on pharma, biotech, life sciences, health-tech and med-tech sectors a global stage to exhibit their innovative ideas, the organisers announced on Thursday.

The 20th of BioAsia is expected to attract the participation of more than 3,000 global participants from over 50 countries.

The Innovation Zone has received an overwhelming response from the startup community, receiving over 400 applicants from around the world, including from Singapore, Thailand, the US, Ireland, and the UK.

These startups will be provided space to showcase their invocation at the exhibition. The scrutinisation of the applications was based on peculiarity, affordability, and the idea/product’s ability to fulfil the demand.

PE and VC firms, investment banks, and angel investors have been invited to the event where budding startups will be given the opportunity to network and explore potential collaborations.

The participating startups will be provided access to all conferences and sessions along with an opportunity to network with the industry leaders. In due course, five startups will be selected by the jury panel to exhibit at the main BioAsia Valedictory session and will also be given exclusive pitch time for each team.

They will also be handed over a cash prize along with credits for Amazon cloud. The startup stage is being organised in partnership with Tech Mahindra and BIRAC, Government of India.

Jayesh Ranjan, Principal Secretary (I&C and IT), Government of Telangana, said that the sheer number of startup deals and funding is a testimony that Hyderabad has ascended to the country’s top five startup hubs.

“BioAsia has gained global repute through the impact generated by its 19 previous editions. Telangana is the proud home for this year’s Innovation Zone, which presents an enormous opportunity for distinctive startups,” he said.

ALSO READ: ‘Rethinking Money and Capital’

BioAsia 2023 to focus on opportunities in life science

According to the organisers, the pandemic has brought into sharp focus the critical need for industry, academia, governments, regulators, and other stakeholders in the ecosystem to intensify their collaboration for ensuring healthcare innovation…reports Asian Lite News

BioAsia 2023, Asia’s largest life-sciences and healthcare forum, scheduled to be held next month, will discuss the learnings, challenges and opportunities in life science post-Covid-19, organisers said.

The 20th edition of BioAsia – the marquee healthcare and life sciences event, organized by the Telangana government, will feature prominent government dignitaries, industry leaders, researchers, entrepreneurs, and other delegates, and explore the theme of Advancing for ONE: Shaping the next generation of humanized healthcare.

The event is scheduled to be held between February 24 and 26, at the Hyderabad International Convention Center (HICC) in Hyderabad. Ernst and Young will be the knowledge partner of the event.

According to the organisers, the pandemic has brought into sharp focus the critical need for industry, academia, governments, regulators, and other stakeholders in the ecosystem to intensify their collaboration for ensuring healthcare innovation at scale and delivery with equitable access.

Moving back to a in-person format, the event will witness the participation of some of the most renowned and influential global leaders inclung Dr Vas (Vasanth) Narasimhan, CEO, Novartis, Switzerland, Prof. Robert Langer of MIT And Co-Founder, Moderna Inc, US, Dr Richard Hatchett, CEO, CEPI (Coalition for Epidemic Preparedness Innovations), UK, Dr Rahul Singhvi, CEO, Resilience, US, Dr Mark Abdoo, Associate Commissioner for Global Policy and Strategy, US-FDA, Dr Gregory Moore, Vice President of Corporate Planning at Microsoft, Prof Sarfaraz K. Niazi, Adj Professor of Pharmaceutical Sciences, University of Illinois, Chicago, US, and Dr Samit Hirawat, Executive Vice President and Chief Medical Officer for the Global Drug Development division, Bristol-Myers Squibb, US.

There will also be a number of distinguished speakers from the Indian industry at the event including Dr. Sangita Reddy, Joint Managing Director of Apollo Hospitals, Satish Reddy, Chairman, Dr. Reddy’s Laboratories, Dr. Gagandeep Kang, virologist, and Professor, Dept. of Gastrointestinal Sciences, CMC Vellore, Dr. S. Chandrasekhar, Secretary, Science & Technology, Glenn Saldanha, Chairman And Managing Director, Glenmark Pharmaceuticals,Sanjiv Navangul, MD & CEO, Bharat Serums and Vaccines Ltd, and Dr. Rehan Khan, MD, MSD India.

These speakers will highlight the growing role of India in the global life sciences market and also deliberate on the opportunities/challenges for India as the companies look to scale further heights.

“Telangana has been playing a significant role in strengthening the positioning of the country in the worldwide life sciences industry. Several key global players have been leveraging the ecosystem provided by the state by setting up their operations in the state. BioAsia has created a legacy by providing a platform for global leaders to deliberate on healthcare’s key requirements over the last 20 years. I am confident that the world will continue to hear and learn from the brilliant minds at the conference,” Telangana’s Industry and Information Technology Minister K.T. Rama Rao said.

Telanagana’s Principal Secretary, Industries & Commerce, Jayesh Ranjan, said BioAsia hosted over 20,000 B2B, B2R, and R2R meetings that led to strategic business deals, making Telangana the life sciences capital of the world. Over 250 Lols, Bilateral Cooperation agreements, and MoUs were signed and over 30 knowledge papers and policy recommendations were also implemented.

“The conference will deliberate on some of the most relevant aspects of the life sciences/healthcare industry including the potential strategies for operationalising the one health approach, building more resilient supply chains in light of the current geopolitical trends, opportunities for the Indian medtech industry and the issues plaquing the growth, role of technologies like AI, ML metverse in healthcare, regulatory and government support required to accelerate growth and make innovative therapies available to patients at affordable cost, adopting ESG as a culture, among others,” Telanagana’s Director of Life Sciences, and BioAsia CEO Shakthi Nagappan said.

ALSO READ: ‘Rethinking Money and Capital’

ALSO READ: Two recessions in same decade?